There are two types of Inflammatory bowel diseases (IBD): Ulcerative colitis (UC) and Crohn’s disease (CD). Both UC and CD are chronic, relapsing, remitting, inflammatory conditions of the gastrointestinal (GI) tract that are often progressive in nature. UC only involves the large intestine as opposed to CD which can affect any part of the GI tract from mouth to anus. The cause of UC or CD is not fully understood, however recent research suggests hereditary, genetics, environmental factors and/or an abnormal immune response to microbial antigens in genetically predisposed individuals can lead to UC or CD.
In Belgium, 30.000 patients suffer from inflammatory bowel diseases.
Takeda Belgium aims at improving the lives of patients with GI diseases through the delivery of innovative medicines and with dedicated patient disease management support, both for patients and healthcare professionals.
With web sites dedicated to CD and to UC, both available in Dutch and in French, Takeda Belgium offers patients a platform where they find scientific and practical information and where they can share their experiences of living with an IBD.